Drug-coated balloon angioplasty in coronary artery disease: state of the art review
Panagiotis Theofilis, Aggelos Papanikolaou, Kyriakos Dimitriadis, Paschalis Karakasis, Panagiotis Iliakis, Konstantinos Aznaouridis, Konstantinos Tsioufis, Dimitris Tousoulis · 2026
Read Drug-coated balloon angioplasty in coronary artery disease: state of the art review by Panagiotis Theofilis, Aggelos Papanikolaou, Kyriakos Dimitriadis, Paschalis Karakasis, Panagiotis Iliakis, Konstantinos Aznaouridis, Konstantinos Tsioufis, Dimitris Tousoulis (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13241482.txt.
Description
Theofilis and team review drug-coated balloons for heart artery disease in twenty twenty-six, a state-of-the-art survey. These balloons deliver vessel-opening medicine yet leave no stent behind. Balloons needed more repeat work than drug-eluting stents for reopened stented segments and new lesions. In small vessels, results matched stents or were at times better. For complex lesions and high-risk patients, set studies show the method can work, with hints it is not worse. The leave-nothing-behind plan stays attractive where implants are risky.
Catalog record
| CREATOR | Panagiotis Theofilis, Aggelos Papanikolaou, Kyriakos Dimitriadis, Paschalis Karakasis, Panagiotis Iliakis, Konstantinos Aznaouridis, Konstantinos Tsioufis, Dimitris Tousoulis |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |